Enstar Group LTD Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Interim condensed consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020
ASSETS
Investments, trading, at fair value
Fixed maturity securities
Short-term Investments
InRe Fund

Available-for-sale, at fair value
Fixed maturity securities
Short-term Investments
Total available-for-sale, at fair value
Investments, available-for-sale, at fair value
Fixed maturity securities
Short-term Investments
Total investments, available-for-sale, at fair value
Funds held - directly managed
Funds held
Equity securities, at fair value (cost: 2025 — $725; 2024 — $680)
InRe Fund
Total equity securities, at fair value (cost: 2025 — $725; 2024 — $680)

Other investments, at fair value
Other investments, at fair value (includes consolidated variable interest entity: 2025 - $120; 2024 - $112)
InRe Fund
Total other investments, at fair value (includes consolidated variable interest entity: 2025 - $120; 2024 - $112)
Equity method investments
Investments (Note 5 and Note 10)
Consolidated Entity, Excluding Consolidated VIE
InRe Fund
Total investments (Note 5 and Note 10)

Cash and cash equivalents (includes consolidated variable interest entity: 2025 — $1; 2024 — $5)
Consolidated Entity, Excluding Consolidated VIE
InRe Fund
Total cash and cash equivalents (includes consolidated variable interest entity: 2025 — $1; 2024 — $5)

Restricted cash and cash equivalents
Consolidated Entity, Excluding Consolidated VIE
InRe Fund
Total restricted cash and cash equivalents

Premiums receivable
Deferred tax assets (Note 19)
Reinsurance balances recoverable on paid and unpaid losses (net of allowance: 2022 — $135; 2021 — $136)
Accrued interest receivable
Reinsurance balances recoverable on paid and unpaid losses (net of allowance: 2025 — $115; 2024 — $116)
Funds held by reinsured companies
Deferred acquisition costs
Goodwill and intangible assets (Note 13)
Reinsurance balances recoverable on paid and unpaid losses, at fair value (Note 10)
Insurance balances recoverable (net of allowance: 2025 and 2024 — $4) (Note 9)
Net deferred charge assets (Note 7)
Other assets
Consolidated Entity, Excluding Consolidated VIE
InRe Fund
Total other assets

Assets held-for-sale (Note 5)
InRe Fund
TOTAL ASSETS
Cash and restricted cash
InRe Fund
Total cash and restricted cash

LIABILITIES
Losses and loss adjustment expenses (Note 5)
Losses and loss adjustment expenses, at fair value (Note 5 and Note 7)
Losses and loss adjustment expenses (Note 8)
Losses and loss adjustment expenses, at fair value (Note 8 and Note 10)
Future policyholder benefits (Note 12) (1)
Defendant asbestos and environmental liabilities (Note 9)
Unearned premiums
Insurance and reinsurance balances payable
Deferred tax liabilities (Note 19)
Debt obligations (Note 12)
Variable interest entity liabilities of the InRe Fund (Note 12)
Other liabilities (includes consolidated variable interest entity: 2025 and 2024 — $ 2)
InRe Fund
Total other liabilities (includes consolidated variable interest entity: 2025 and 2024 — $ 2)
Liabilities held-for-sale (Note 5)
InRe Fund
TOTAL LIABILITIES

REDEEMABLE NONCONTROLLING INTERESTS (Note 19)
SHAREHOLDERS’ EQUITY (Note 14)
Voting ordinary shares (par value $1 each, issued and outstanding 2025: 14,909,718; 2024: 15,241,316)
Voting Ordinary Shares
Non-Voting Convertible Ordinary Series C Shares
Non-Voting Convertible Ordinary Series E Shares
Preferred Shares
Series D Preferred Shares (issued and outstanding 2025 and 2024: 16,000; liquidation preference $400)
Series E Preferred Shares (issued and outstanding 2025 and 2024: 4,400; liquidation preference $110)
Series C Preferred Shares
Series C Preferred shares (all issued shares held in treasury in 2025 and 2024: 388,571)
Series C Preferred Shares
Total series C Preferred shares (all issued shares held in treasury in 2025 and 2024: 388,571)

Joint Share Ownership Plan (voting ordinary shares, held in trust 2024 — 565,630)
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Enstar shareholders’ equity
InRe Fund
Total Enstar shareholders’ equity

Noncontrolling interests (Note 13)
TOTAL SHAREHOLDERS’ EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
Treasury shares, preferred at cost (in shares)
Series C Preferred Shares
Total treasury shares, preferred at cost (in shares)

Comments